PubMed · 1995 · 14 citations · 0 references
MedicineHematologyImmunologyHematopathologyImmunopathologyInflammationBlood Glucose MonitoringGlucose HomeostasisGlycemic ControlHypoglycemia ManagementDelayed HypoglycemiaGranulocyte Colony-stimulating Factor AdministrationHypoglycemia Diagnostic EvaluationLaboratory Plasma Glucose TestingLeukemoid ReactionMatched Control GroupMetabolic Causes Of HypoglycemiaSodium Fluoride
We observed apparent hypoglycemia in seven patients manifesting granulocytosis associated with hematopoietic cytokine treatment or with a leukemoid reaction. All seven patients had confounding preanalytic conditions of specimen transport delay and lack of antiglycolytic agents. Cytokine-stimulated leukocytes may cause artifactual hypoglycemia by consuming glucose in vitro, possibly leading to unnecessary diagnostic evaluation. The glucose depletion was faster in blood drawn from patients receiving granulocyte colony-stimulating factor (0.29 mmol/L/h) than in blood from a control group (0.17 mmol/L/h) or from a group with leukemia (0.23 mmol/L/h). Stabilization with sodium fluoride (60 mmol/L) slowed the glucose depletion in both the cytokine group (0.13 mmol/L/h) and the leukemic group (0.09 mmol/L/h), which were then statistically indistinguishable from the control rate (0.10 mmol/L/h). In blood obtained from patients being treated with hematopoietic cytokines or who have leukemoid reactions, an antiglycolytic agent should be used whenever separation of plasma might be delayed more than 1 hour.